FDA Clears First OTC Continuous Glucose Monitor for Kids
19/06/2026
The FDA cleared the first over-the-counter (OTC) integrated continuous glucose monitor (CGM) for children 2 years and older with or
The FDA cleared the first over-the-counter (OTC) integrated continuous glucose monitor (CGM) for children 2 years and older with or
CHICAGO — A multidisciplinary group of menopause experts developed new comorbidity-specific guidance on non-hormone therapy for moderate-to-severe vasomotor symptoms. First-Line
Brain Tumor Report Brain tumors diagnosed in 11 nurses at Newton-Wellesley Hospital in suburban Boston were not caused by any
Introducción Fixed-duration therapy with pirtobrutinib (Jaypirca) plus venetoclax (Venclexta) and rituximab improved progression-free survival (PFS) in patients with relapsed/refractory chronic
Prone positioning of infants on high-flow nasal cannula oxygen support for bronchiolitis didn’t significantly reduce risk of progression to needing